ESC 365 - Alirucumab in cardiac rehabilitation patients. Clinical profile and initial results.

EAPC Premium Access

Alirucumab in cardiac rehabilitation patients. Clinical profile and initial results.

Session: Poster Session 3 - Cardiovascular pharmacology

Topic: Pharmacology and Pharmacotherapy, Other

Speaker: Doctor A. Rojas Sanchez (Malaga, ES)

Event: EuroPrevent 2018

Congress Presentation

About the speaker

Doctor Antonio Aurelio Rojas Sanchez

Regional University Hospital Carlos Haya, Malaga (Spain)

0 follower

4 more presentations in this session

Cardiovascular pharmacology - Poster discussant:

Adverse effects of drug therapy (the first results of the study according to the outpatient register)

Speaker: Doctor Y. Lukina (Moscow, RU)

Improving adherence to medicines of secondary prevention - results of a prospective multicenter follow-up study

Statins and risk biomarkers for coronary heart disease (CHD) in type 2 diabetes mellitus patients with normal LDL cholesterol levels. 1 year prospective study in Constanta County, Romania

Speaker: Professor I. Parepa (Constanta, RO)

Access the full session

Poster Session 3 - Cardiovascular pharmacology

Speakers: Doctor A. Rojas Sanchez, Doctor Y. Lukina, Professor I. Parepa

About the event

EuroPrevent 2018

19 April - 21 April 2018

Sessions Presentations

Congress

ESC 365 is supported by